講演情報
[LOP6-4]Neoadjuvant ALK-TKI therapy for ALK-positive non-small cell lung cancer：updated outcomes from a single-center study and a meta-analysis of relevant publications
Siying Ren1, Yan Hu2, Wenliang Liu2 (1.Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital of Central South University, 2.Department of Thoracic Surgery, the Second Xiangya Hospital of Central South University)
閲覧にはパスワードが必要です
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン